-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UVmJclCwmRfTbfbQeRABCVnzCx+nGPOAkwbe2KRswRYFAamp5D29IDlMgOfIfS5F v8oshwsCnr9CHIJf5J7P/A== 0000885590-10-000047.txt : 20100930 0000885590-10-000047.hdr.sgml : 20100930 20100930212536 ACCESSION NUMBER: 0000885590-10-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100928 FILED AS OF DATE: 20100930 DATE AS OF CHANGE: 20100930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE SILVA RAJIV CENTRAL INDEX KEY: 0001453140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 101100467 MAIL ADDRESS: STREET 1: ONE ENTERPRISE CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-09-28 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001453140 DE SILVA RAJIV 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 President & COO Common Stock, no par value 2010-09-28 4 A 0 410576 0 A 410576 D Common Stock, no par value 2010-09-28 4 A 0 73663 0 A 484239 D Incentive Stock Options (right to purchase) 8.11 2010-09-28 4 A 0 39129 8.11 A 2019-01-05 Common Stock, no par value 39129 39129 D Non-Qualified Stock Option (right to purchase) 8.11 2010-09-28 4 A 0 227020 8.11 A 2019-01-05 Common Stock, no par value 227020 227020 D Non-Qualified Stock Options (right to purchase) 13.75 2010-09-28 4 A 0 208790 13.75 A 2017-03-03 Common Stock, no par value 208790 208790 D Represents long-term performance units (the "Performance Units") received upon conversion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") Performance Units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the Merger agreement between the issuer and, amongst others, old Valeant. The Performance Units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. Represents restricted share units received upon conversion of the reporting person's old Valeant restricted stock units that were held prior to the Merger. The restricted share units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. Received upon conversion of the reporting person's old Valeant incentive stock options of that were held prior to the Merger. The stock options were initially granted on January 5, 2009 and have not yet vested. Received upon conversion of the reporting person's old Valeant non-qualified stock options that were held prior to the Merger. The stock options were initially granted on January 5, 2009 and vest in four equal annual installments. 56,756 Stock Options were exercisable as of January 5, 2010 and the remaining three installments will vest and become exercisable on January 5 of 2011, 2012 and 2013. The stock options were initially granted on March 3, 2010 and will vest in four equal annual installments on March 3rd of 2011, 2012, 2013 and 2014. By: Angie Palmer For: Rajiv De Silva 2010-09-30 -----END PRIVACY-ENHANCED MESSAGE-----